Skip to main content

Table 2 Statistical summary of significantly altered biochemicals

From: Metabolomic changes related to airway inflammation, asthma pathogenesis and systemic activity following inhaled fluticasone furoate/vilanterol: a randomized controlled trial

Repeated-measures ANOVA

T1 FF/VI vs placebo

T2 FF/VI vs placebo

T3 FF/VI vs placebo

Total number of biochemicals with p ≤ 0.05

42

132

232

Biochemicals (increase ¦ decrease)

22 ¦ 20

9 ¦ 123

17 ¦ 215

% significant

2

7

12

  1. ANOVA, analysis of variance; FF/VI, fluticasone furoate/vilanterol trifenatate; T1, baseline; T2, Day 15; T3, Day 21